Question 1

How many stocks does Avoro Capital Advisors LLC own?

Accepted Answer

As of Q4 2025, Avoro Capital Advisors LLC holds 33 positions in their 13F portfolio.

Question 2

What is Avoro Capital Advisors LLC's largest holding?

Accepted Answer

UTHR at 12.5% of portfolio, worth $1.3B.

Question 3

What is Avoro Capital Advisors LLC's total portfolio value?

Accepted Answer

$10.2B as of Q4 2025, tracked across 33 holdings.

Question 4

Is Avoro Capital Advisors LLC a hedge fund?

Accepted Answer

Avoro Capital Advisors LLC is an institutional investment manager required to file SEC 13F reports. This includes hedge funds, mutual funds, pension funds, and other institutions managing over $100M.

Question 5

How often does Avoro Capital Advisors LLC report?

Accepted Answer

13F filings are due quarterly, approximately 45 days after each quarter end.

Question 6

How has Avoro Capital Advisors LLC's portfolio changed in Q4 2025?

Accepted Answer

View Avoro Capital Advisors LLC's latest portfolio changes, new positions, and exits for Q4 2025 on HoldingsIntel.

Question 7

What is Avoro Capital Advisors LLC's investment strategy?

Accepted Answer

Avoro Capital Advisors LLC is classified as a Momentum Trader fund based on HoldingsIntel's Fund DNA analysis of 6 behavioral dimensions.

Stock	Shares	Value	Weight	Price Trend	Avg Buy	Est. P&L	Held	Conviction
UTHR UNITED THERAPEUTICS CORP DEL	2.6M	$1.3B	12.5%	—	$228.72	+116.94%	21 qtrssince 2020-Q4	Increased 79
ASNDADR ASCENDIS PHARMA A/S	5.1M	$1.1B	10.7%	—	$129.53	+61.61%	19 qtrssince 2021-Q2	Increased 63
MDGL MADRIGAL PHARMACEUTICALS INC	1.8M	$1.1B	10.3%	—	$157.20	+170.91%	28 qtrssince 2019-Q1	Decreased 0
ARGXADR ARGENX SE SPONSORED ADR	990,000	$832.5M	8.2%	—	$224.78	+272.77%	28 qtrssince 2019-Q1	Unchanged 0
KRYS KRYSTAL BIOTECH INC	2.9M	$712.2M	7.0%	—	$104.94	+136.20%	17 qtrssince 2021-Q4	Increased 65
ARWR ARROWHEAD PHARMACEUTICALS IN	10.6M	$705.4M	6.9%	—	$27.02	+137.23%	11 qtrssince 2023-Q2	Decreased 0
KYMR KYMERA THERAPEUTICS INC	7.5M	$581.6M	5.7%	—	$39.66	+96.98%	18 qtrssince 2021-Q3	Increased 72
GPCRADR STRUCTURE THERAPEUTICS INC	6.6M	$455.9M	4.5%	—	$34.37	+97.20%	2 qtrssince 2025-Q3	Increased 72
RNA AVIDITY BIOSCIENCES INC	5.5M	$393.5M	3.9%	—	$28.19	-44.42%	23 qtrssince 2020-Q2	Decreased 0
CNTAADR CENTESSA PHARMACEUTICALS PLC	14.6M	$364M	3.6%	—	$21.02	+17.68%	4 qtrssince 2025-Q1	Increased 75
Showing 10 of 34 results.24 more with Pro.PROUpgrade to see all →

Avoro Capital Advisors LLC

Position Outcomes

Top Winners

Top Losers

Top Holdings10 of 34

Explore More

Accumulation Streaks

Continue exploring